DK1039900T3 - Farmaceutisk præparat indeholdende sibutramin og orlistat - Google Patents

Farmaceutisk præparat indeholdende sibutramin og orlistat

Info

Publication number
DK1039900T3
DK1039900T3 DK98966345T DK98966345T DK1039900T3 DK 1039900 T3 DK1039900 T3 DK 1039900T3 DK 98966345 T DK98966345 T DK 98966345T DK 98966345 T DK98966345 T DK 98966345T DK 1039900 T3 DK1039900 T3 DK 1039900T3
Authority
DK
Denmark
Prior art keywords
compound
formula
orlistat
pharmaceutical preparation
preparation containing
Prior art date
Application number
DK98966345T
Other languages
Danish (da)
English (en)
Inventor
David John Heal
Helen Christine Jackson
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Application granted granted Critical
Publication of DK1039900T3 publication Critical patent/DK1039900T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK98966345T 1997-12-24 1998-12-16 Farmaceutisk præparat indeholdende sibutramin og orlistat DK1039900T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9727131.6A GB9727131D0 (en) 1997-12-24 1997-12-24 Therapeutic agents

Publications (1)

Publication Number Publication Date
DK1039900T3 true DK1039900T3 (da) 2004-10-04

Family

ID=10824083

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98966345T DK1039900T3 (da) 1997-12-24 1998-12-16 Farmaceutisk præparat indeholdende sibutramin og orlistat

Country Status (26)

Country Link
US (1) US6403641B2 (de)
EP (1) EP1039900B1 (de)
JP (1) JP2001527036A (de)
KR (1) KR20010033531A (de)
CN (1) CN1134257C (de)
AT (1) ATE268174T1 (de)
AU (1) AU758181B2 (de)
BG (1) BG104568A (de)
BR (1) BR9814498A (de)
CA (1) CA2315259A1 (de)
CZ (1) CZ20002392A3 (de)
DE (1) DE69824313T2 (de)
DK (1) DK1039900T3 (de)
ES (1) ES2222001T3 (de)
GB (1) GB9727131D0 (de)
HK (1) HK1034446A1 (de)
HU (1) HUP0300615A3 (de)
IL (1) IL136733A (de)
NO (1) NO20003313L (de)
NZ (1) NZ505686A (de)
PL (1) PL342099A1 (de)
PT (1) PT1039900E (de)
SK (1) SK9492000A3 (de)
TR (1) TR200001869T2 (de)
UA (1) UA70310C2 (de)
WO (1) WO1999033450A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
GB9914744D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
RU2241462C2 (ru) 2000-07-28 2004-12-10 Ф. Хоффманн-Ля Рош Аг Новая фармацевтическая композиция
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US6730319B2 (en) * 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US20060166957A1 (en) * 2003-06-12 2006-07-27 Menachem Rubinstein Methods of treating obesity and related disorders using tellurium selenium compounds
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
CA2564632C (en) 2004-05-10 2019-06-18 Den Kgl. Veterinaer - Og Landbohojskole Flaxseeds for body weight management
EP2190303A1 (de) 2007-09-12 2010-06-02 Københavns Universitet Zusammensetzungen und methoden zur verstärkung der hungerunterdrückung und zum reduzieren der verdaulichkeit der nichtfettenergiesättigung
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
JP5738011B2 (ja) * 2011-03-04 2015-06-17 株式会社ブリヂストン 二次電池の非水電解液用添加剤、二次電池用非水電解液及び非水電解液二次電池
CN102872062A (zh) * 2011-07-13 2013-01-16 鲁南制药集团股份有限公司 一种治疗或预防肥胖症以及代谢综合症的药物组合物
JP2013147488A (ja) * 2011-12-21 2013-08-01 Taisho Pharmaceutical Co Ltd 固形製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52768B1 (en) 1981-04-06 1988-02-17 Boots Co Ltd 1-arylcyclobutylalkylamine compounds useful as therapeutic agents
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
GB8531071D0 (en) 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
CA2128044C (en) 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
US5459164A (en) 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
PL342099A1 (en) 2001-05-21
NO20003313L (no) 2000-08-11
DE69824313T2 (de) 2005-08-25
ATE268174T1 (de) 2004-06-15
AU2273899A (en) 1999-07-19
WO1999033450A3 (en) 1999-09-02
BG104568A (bg) 2001-02-28
HUP0300615A2 (hu) 2003-07-28
CA2315259A1 (en) 1999-07-08
EP1039900A2 (de) 2000-10-04
EP1039900B1 (de) 2004-06-02
IL136733A (en) 2004-08-31
AU758181B2 (en) 2003-03-20
JP2001527036A (ja) 2001-12-25
US20020010160A1 (en) 2002-01-24
KR20010033531A (ko) 2001-04-25
CN1284872A (zh) 2001-02-21
UA70310C2 (uk) 2004-10-15
ES2222001T3 (es) 2005-01-16
US6403641B2 (en) 2002-06-11
IL136733A0 (en) 2001-06-14
PT1039900E (pt) 2004-09-30
CZ20002392A3 (cs) 2002-01-16
SK9492000A3 (en) 2001-07-10
TR200001869T2 (tr) 2000-10-23
HK1034446A1 (en) 2001-10-26
HUP0300615A3 (en) 2005-04-28
NZ505686A (en) 2002-07-26
CN1134257C (zh) 2004-01-14
BR9814498A (pt) 2000-10-10
NO20003313D0 (no) 2000-06-23
DE69824313D1 (de) 2004-07-08
WO1999033450A2 (en) 1999-07-08
GB9727131D0 (en) 1998-02-25

Similar Documents

Publication Publication Date Title
DK1039900T3 (da) Farmaceutisk præparat indeholdende sibutramin og orlistat
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
LU91254I2 (fr) Daptomycine et ses dérivés pharmaceutiquement acceptables (cubicinr)
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
NO2005019I1 (no) Metylaminolevulina, eventuelt i form av et salt, fortinnsvis metylaminolevulinat-hydroklorid
MX9707453A (es) Derivados de quinazolina.
DK1014966T3 (da) Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser
DK0998287T3 (da) Anvendelse af levobupivacain
DK0652000T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme
ATE319715T1 (de) Antikonvulsive pseudofructopyranose sulfamate
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
BG106209A (en) Therapeutic agents
SE0004827D0 (sv) Therapeutic compounds
MD1469G2 (ro) Metodă de tratament al şocului combustional
WO2003004019A8 (en) Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia
RU99118112A (ru) Способ лечения больных с невротическими расстройствами препаратом "миелопид"
UA15281A (uk) Спосіб лікуваhhя хроhічhої ішемічhої хвороби серця